Literature DB >> 32235929

Mitochondrial dysfunction manifests in the early stages of Alzheimer disease.

Heather Wood1.   

Abstract

Entities:  

Year:  2020        PMID： 32235929     DOI： 10.1038/s41582-020-0353-3

Source DB:  PubMed          Journal:  Nat Rev Neurol        ISSN： 1759-4758            Impact factor:   42.937


× No keyword cloud information.
  1 in total

1.  Safety and efficacy of satralizumab monotherapy in neuromyelitis optica spectrum disorder: a randomised, double-blind, multicentre, placebo-controlled phase 3 trial.

Authors:  Anthony Traboulsee; Benjamin M Greenberg; Jeffrey L Bennett; Lech Szczechowski; Edward Fox; Svitlana Shkrobot; Takashi Yamamura; Yusuke Terada; Yuichi Kawata; Padraig Wright; Athos Gianella-Borradori; Hideki Garren; Brian G Weinshenker
Journal:  Lancet Neurol       Date:  2020-05       Impact factor: 44.182
  1 in total
  3 in total

1.  CRISPR/dCas9 for hepatic fibrosis therapy: implications and challenges.

Authors:  Nianan Luo; Wenjun Zhong; Jiangbin Li; Jianguo Lu; Rui Dong
Journal:  Mol Biol Rep       Date:  2022-08-12       Impact factor: 2.742

2.  Molecular Signatures of Mitochondrial Complexes Involved in Alzheimer's Disease via Oxidative Phosphorylation and Retrograde Endocannabinoid Signaling Pathways.

Authors:  Fenqin Chen; Jun Bai; Shanshan Zhong; Rongwei Zhang; Xiaoqian Zhang; Ying Xu; Mei Zhao; Chuansheng Zhao; Zhike Zhou
Journal:  Oxid Med Cell Longev       Date:  2022-04-05       Impact factor: 6.543

Review 3.  Mitochondrial Permeability Transition: A Pore Intertwines Brain Aging and Alzheimer's Disease.

Authors:  Kun Jia; Heng Du
Journal:  Cells       Date:  2021-03-15       Impact factor: 7.666
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.